Comparison Chart ORIC Pharmaceuticals, Inc.
Stocks
ORIC
US68622P1093
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
07:00:00 29/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 9.300 USD | +3.33% |
|
-32.51% | +13.69% |
| 27/10 | Wedbush Adjusts Price Target on ORIC Pharmaceuticals to $14 From $17, Keeps Outperform Rating | MT |
| 24/10 | ORIC Pharmaceuticals, Inc. - Special Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Bio Therapeutic Drugs | +3.33% | -32.51% | +13.69% | -30.60% | -37.29% | 933M |  |  | |
- Stock Market
- Stocks
- ORIC Stock
- Charts ORIC Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
